Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 6/20 | 0.64 |
| ▸ | MAOB | P27338 | 11/20 | 0.59 |
| ▸ | MAOA | P21397 | 9/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1325521 | 1.00 | AR (0.64) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL1325395 | 1.00 | AR (0.64) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL13811418 | 0.86 | AR (0.71) | ARMAOBMAOAKDM4EGAA | |
| SCHEMBL2552925 | 0.81 | TSHR (0.50) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL2557627 | 0.81 | TSHR (0.50) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL8565067 | 0.81 | TSHR (0.50) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL8569987 | 0.81 | TSHR (0.50) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL2550694 | 0.81 | TSHR (0.50) | ARMAOBMAOAALDH1A1HPGD | |
| SCHEMBL8955587 | 0.80 | AR (0.64) | ARMAOBMAOAALDH1A1KDM4E | |
| SCHEMBL2979985 | 0.79 | KDM4E (0.54) | ARMAOBMAOAALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947826-B2 | Phthalocyanine compound based-organic semiconductor | FUJIFILM CORPORATION (JP) | 2011-05-24 | — | — | US | disclosed |
| US-20080210128-A1 | Optical Layer including mu-oxo-bridged boron-subphthalocyanine dimer | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1964892-A2 | Optical layer including µ-oxo-bridged boron-subphthalocyanine dimer | Orient Chemical Industries, Ltd. (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-20080142790-A1 | Phthalocyanine compound; organic semiconductor and method of producing the same, electronic device, organic photoelectric conversion device, organic field-effect transistor, and organic electroluminescence device, using the compound | FUJIFILM CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080210128-A1 | Optical Layer including mu-oxo-bridged boron-subphthalocyanine dimer | SAAL1, APOL1, EBPL | AR 3319/4885MAOB 572/4885MAOA 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.